INVERNESS COUNSEL LLC /NY/ - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
INVERNESS COUNSEL LLC /NY/ ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2020$220,000
-13.7%
6,113
-6.3%
0.01%
-18.2%
Q3 2020$255,000
-11.1%
6,523
-16.7%
0.01%
-21.4%
Q2 2020$287,000
+19.1%
7,834
-4.7%
0.01%
+27.3%
Q4 2019$241,000
+8.1%
8,223
-1.5%
0.01%
-8.3%
Q3 2019$223,000
+4.7%
8,344
-0.1%
0.01%
+9.1%
Q2 2019$213,000
+3.9%
8,349
-8.5%
0.01%0.0%
Q1 2019$205,000
-27.6%
9,123
-32.0%
0.01%
-42.1%
Q4 2018$283,000
+12.7%
13,415
-0.9%
0.02%
+46.2%
Q3 2018$251,000
-30.1%
13,532
-15.8%
0.01%
-35.0%
Q2 2018$359,000
-0.3%
16,071
-1.9%
0.02%
-9.1%
Q1 2018$360,000
-5.8%
16,390
-0.3%
0.02%
-8.3%
Q4 2017$382,000
-2.3%
16,435
-3.4%
0.02%
-14.3%
Q3 2017$391,000
-6.9%
17,020
-10.6%
0.03%
-3.4%
Q2 2017$420,000
-10.1%
19,035
+0.2%
0.03%
-12.1%
Q1 2017$467,000
-3.5%
18,995
-6.3%
0.03%
-10.8%
Q4 2016$484,000
-1.0%
20,275
+9.6%
0.04%
-2.6%
Q3 2016$489,000
+10.1%
18,500
+15.4%
0.04%
+8.6%
Q2 2016$444,00016,0250.04%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders